Transvaginal Mesh

Transvaginal Mesh Warnings and Litigation

CaseyGerry is not currently accepting cases for this matter.

The Food and Drug Administration (FDA) has received more than 3,000 reports of complications associated with transvaginal mesh – surgical devices used to repair pelvic organ prolapse (POP) and stress urinary incontinence (SUI).

A net-like implant device, transvaginal mesh is typically made of porous absorbable or non-absorbable synthetic material or absorbable biologic material. The term “transvaginal” means through the vagina – and refers to the surgery used to implant the mesh.

The Warning:

Transvaginal mesh products are inserted into the abdomen or pelvis to alleviate pressure on tissue which has been damaged or weakened, often  through hysterectomy, childbirth or menopause. Increasing numbers of women have reported serious complications from the use of these mesh products, which include bladder slings, patches and tape.

In 2008, the FDA issued a safety alert addressing complications related to transvaginal mesh devices.

Three years later, the agency warned that there had been a dramatic increase in reports of problems associated with the use of vaginal mesh.

At this time, the FDA warning about the use of transvaginal surgical meshes to treat pelvic organ prolapse and urinary leakage and noted that thousands of women have reported serious complications. According to the FDA it is “not clear that transvaginal POP repair with mesh is any more effective than traditional repair and may expose patients to greater risk.”

Background

The surgical procedure involving mesh has become more prevalent in recent years. In 2010, more than 75,000 women underwent vaginal surgery with mesh to repair POP.

POP affects many women as they age, with the FDA estimating that up to 50 percent of all women may experience it during their lifetimes. POP occurs when the tissue holding the uterus, bladder, bowel and rectum is weakened, allowing the organs to prolapse – or slip out of place. Pelvic Support Problems

SUI results in leakage of urine, especially if the patient coughs, laughs or exercises.

Typically, surgical mesh is implanted to reinforce the weakened vaginal wall – either to repair pelvic organ prolapse or to support the urethra to treat urinary incontinence. By reinforcing the vaginal wall and urethra, transvaginal mesh is designed to mitigate the negative impact of SUI and POP.

Unfortunately, over time, erosion or contraction of the mesh  can result in serious injuries and complications.

In fact, thousands of women have suffered the effects of improperly placed mesh, and thousands of cases have been consolidated into multidistrict litigation (MDL) in the U.S. District Court of West Virginia.  These lawsuits allege that various models share similar design flaws and risks. The cases were centralized into MDL because they all contain similar sets of facts and injuries.

A variety of mesh devices have been marketed and sold by companies including: Gynecare, American Medical Systems (“AMS”), Boston Scientific, C.R. Bard, Inc., Ethicon and Johnson and Johnson.

However, the complications associated with the use of surgical mesh have not been linked to a single brand.

Transvaginal Mesh Side Effects

The most common complication reported to the FDA for surgical mesh devices involves mesh erosion – which can damage the tissue of the vaginal wall – causing pain, infection, bleeding, organ perforation and urinary problems. Another  potential consequence is mesh shrinkage, which may cause a painful shortening and tightening of the vagina

Equally painful is transvaginal mesh organ perforation, which can occur when the sharp edges of mesh cut into organs.

Ironically, many women have reported a reoccurrence of vaginal prolapse or stress urinary incontinence when using these devices.

How CaseyGerry Can Help

The manufacturers of transvaginal meshes failed to warn about their products’ risk.  Women suffering mesh complications were able to file claims seeking compensation for medical bills, lost wages, pain and suffering and other damages. CaseyGerry is not currently accepting new cases against manufacturers of transvaginal meshes.

The pharmaceutical attorneys at CaseyGerry have decades of experience in the field of medical device litigation. We can offer legal guidance as well as help and support to those who have sustained injuries due to harmful medical devices.